All In Biotech

Drug Trial Radar · NCT05567354

A Study to Evaluate the Intranasal Abuse Potential of PF614 in Non-Dependent Recreational Opioid Users (PF614-103)

A Randomized, Double-blind, Placebo-and Active-Controlled Crossover Study to Evaluate the Intranasal Abuse Potential of PF614 Compared with Immediate-Release Oxycodone and Placebo in Non-Dependent Recreational Opioid Users

Last checked: Nov 19, 2026Latest source record: Sep 24, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

27

Actual

Start

Jun 10, 2022

Primary completion

Aug 31, 2022

Study completion Aug 31, 2022

Sponsor

Lead sponsor
Ensysce BiosciencesIndustry
Sponsor type
Industry
First posted
Oct 5, 2022

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Crossover
Masking
Triple (participant, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 55 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The purpose of this study is to examine the abuse potential and pharmacokinetics of PF614 compared with a non-abuse deterrent, commercially available, immediate release (IR) oxycodone hydrochloride (HCl) formulation and placebo.

Conditions

  • Recreational Drug Use

Interventions

  • PF614Drug

    PF614 100 mg capsules

  • OxycodoneDrug

    Oxycodone HCl IR 40mg

  • PlaceboOther

    placebo powder

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Peak Maximum Effect (Emax) for Drug Liking (At this Moment) Visual Analog Scale (VAS)Time frame: Up to 24 hour post-dose (up to Day 2)
  2. Take Drug again VAS (Emax)Time frame: 12 and 24 hours post-dose

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Ohio Clinical Trails

    Columbus, Ohio

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.